RBC Capital starts Advanced Medical Solutions at ‘sector perform’
Advanced Medical Solutions Group
199.40p
12:40 24/12/24
RBC Capital Markets initiated coverage of Advanced Medical Solutions on Thursday with a ‘sector perform’ rating and 285p price target, as it sees a clear path to a re-rating but remains on the sidelines until then.
FTSE AIM 100
3,464.93
13:14 24/12/24
FTSE AIM 50
3,897.43
13:14 24/12/24
FTSE AIM All-Share
717.40
13:14 24/12/24
Health Care Equipment & Services
10,763.40
12:54 24/12/24
It said AMS is a well-run, cash generative business that is set to bolster its already-impressive positioning in defensive end markets with a range of recent and upcoming launches.
"However, the current share price is already full, in our view, and our £2.85/share price target has insufficient implied upside for us to recommend buying the shares at this stage," it said.
RBC said its sees "meaningful" upside potential from surgical sealant Seal-G, and may revisit its rating on positive clinical and commercial developments.
AMS develops and manufactures tissue-healing technology.